Accumulating evidence in recent studies has consistently demonstrated that the expression levels of H19 are upregulated in a variety of cancer types, including gastric cancer [17], esophageal cancer [18] colorectal cancer [19–21], breast cancer [22, 23], bladder cancer [24, 25], and hepatocellular carcinoma [26, 27]. This evidence concerns the gene H19 and cancer.